KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Elanco Animal Health (ELAN) Shares Issued (2020 - 2021)

Elanco Animal Health's Shares Issued history spans 2 years, with the latest figure at $500.0 million for Q4 2021.

  • On a quarterly basis, Shares Issued changed N/A to $500.0 million in Q4 2021 year-over-year; TTM through Dec 2021 was $500.0 million, a 59.02% decrease, with the full-year FY2022 number at $425.0 million, down 15.0% from a year prior.
  • Shares Issued hit $500.0 million in Q4 2021 for Elanco Animal Health, down from $1.2 billion in the prior quarter.
  • Over the last five years, Shares Issued for ELAN hit a ceiling of $1.2 billion in Q1 2020 and a floor of $500.0 million in Q4 2021.